HAYDEE DIVINO: Open Payments
NPI 1598151979 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,447 in 12 payments from 8 companies in 2025. Trend: 2023 $1,197 · 2024 $1,465 · 2025 $1,447
Food & beverage: $1,447
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 3 | $419 |
| Lilly USA, LLC | 3 | $328 |
| Boston Scientific Corporation | 1 | $138 |
| Corcept Therapeutics | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $120 |
| E.R. Squibb & Sons, L.L.C. | 1 | $116 |
| Ascensia Diabetes Care Us Inc. | 1 | $104 |
| Madrigal Pharmaceuticals | 1 | $98 |
Products named: Barostim Neo System, ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter, Korlym, VOQUEZNA, CAMZYOS, ZEPBOUND, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
